InFlectis BioScience IFB-088 enters phase 1 Clinical Trial
Nantes, France – May 22th, 2018. InFlectis BioScience SAS, a drug discovery company committed to the development of innovative therapeutics … Continue reading InFlectis BioScience IFB-088 enters phase 1 Clinical Trial
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
